Cited by 143Coenzyme Q10 studies and effectsParkinson's Disease Mechanisms and TreatmentsAntioxidant Activity and Oxidative Stress

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease

Sohmiya, Makoto, Tanaka, Makoto, Wei Tak, Nyou, Yanagisawa, Makoto, Tanino, Yutaka, Suzuki, Yoko, Okamoto, Koichi, Yamamoto, Yorihiro·2004·Journal of the Neurological Sciences

DOI 10.1016/j.jns.2004.05.007

Open this paper in CoChat — free account

Abstract

Oxidative stress is suggested to play an important role in the pathogenesis of Parkinson's disease (PD). However, no elevation of plasma oxidative stress marker has been reported. We measured percent content of the oxidized form of coenzyme Q10 in total coenzyme Q10 (%CoQ-10) because %CoQ-10 has been shown to be a sensitive marker of oxidative stress. A slight but significant elevation in %CoQ-10 was observed in PD patients when compared with age/gender-matched normal subjects, suggesting elevated systemic oxidative stress in PD patients.

Integrity signals

Registry

Crossref · 10.1016/j.jns.2004.05.007

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Unified Parkinson's Disease Rating Scale
(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061

Show all 52 references

Research works printed but not linked: 1

Sanchez-Ramos, 1994, A marker of oxyradical-mediated DNA damage (8-hydroxy-2′ deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain, Neurodegeneration, 3, 197

Sorted by citations

Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Rahman, H. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,221
Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
Oxidative Stress in Parkinson's Disease
Zhou, C. H., Huang, Y., & Przedborski, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.023 · Cited by 460
The pathogenesis of cell death in Parkinson's disease
Jenner, P. G., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 451
The Role of Oxidative Stress in Parkinson’s Disease
Chang, K., & Chen, C. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 369
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
Total cholesterol and the risk of Parkinson disease
Hu, G., Antikaínen, R., Jousilahti, P., Kivipelto, M., & Tuomilehto, J. (2008) · Neurology · doi:10.1212/01.wnl.0000312511.62699.a8 · Cited by 205
Serum Cholesterol Levels and the Risk of Parkinson's Disease
de Lau, L. M. L., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj283 · Cited by 205
Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Dai, L., Zou, L. B., Meng, L., Qiang, G., Yan, M., & Zhang, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02232-6 · Cited by 203
Coenzyme Q10 effects in neurodegenerative disease
Henchcliffe, C. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5212 · Cited by 189
Clinical applications of coenzyme Q₁₀
Garrido-Maraver, J. (2014) · Frontiers in Bioscience · doi:10.2741/4231 · Cited by 178
Recent Advances in Biomarkers for Parkinson’s Disease
He, R., Yan, X., Guo, J., Xu, Q., Tang, B., & Sun, Q. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00305 · Cited by 187
Therapeutic effects of coenzyme Q 10 (CoQ 10 ) and reduced CoQ 10 in the MPTP model of Parkinsonism
Cléren, C., Yang, L., Lorenzo, B. J., Calingasan, N. Y., Schomer, A. C., Sireci, A. N., Wille, E. J., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05097.x · Cited by 158
Coenzyme Q10 Therapy
Garrido‐Maraver, J., Cordero, M. D., Oropesa-Ávila, M., Fernández-Vega, A., de la Mata, M., Pavón, A. D., de Miguel, M., Calero, C. P., Paz, M. V., Cotán, D., et al. (2014) · Molecular Syndromology · doi:10.1159/000360101 · Cited by 161
Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease
Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 151
Coenzyme Q10 and Heart Failure
Sharma, A., Fonarow, G. C., Butler, J., Ezekowitz, J. A., & Felker, G. M. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002639 · Cited by 150
Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 145
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders
Covarrubias‐Pinto, A., Acuña, A. I., Beltrán, F. A., Torres-Díaz, L., & Castro, M. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226095 · Cited by 140
The Promise of Neuroprotective Agents in Parkinson?s Disease
Seidl, S. E., & Potashkin, J. A. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00068 · Cited by 145
Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 139
Targeting mitophagy in Parkinson's disease
Clark, E. H., de la Torre, A. V., Hoshikawa, T., & Briston, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.014294 · Cited by 132
Post-Stroke Cognitive Impairment: A Review Focusing on Molecular Biomarkers
Zhang, X., & Bi, X. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01533-8 · Cited by 128
Coenzyme Q10 deficiency in patients with Parkinson's disease
Mischley, L. K., Allen, J., & Bradley, R. D. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.03.023 · Cited by 111
Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease
Yoritaka, A., Kawajiri, S., Yamamoto, Y., Nakahara, T., Ando, M., Hashimoto, K., Nagase, M., Saito, Y., & Hattori, N. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.022 · Cited by 94
Self-citation
Peripheral markers in neurodegenerative patients and their first-degree relatives
Cristalli, D. O., Arnal, N., Marra, F. A., de Alaniz, M. J. T., & Marra, C. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.001 · Cited by 96
Clinical aspects of coenzyme Q10: an update
Littarru, G. P., & Tiano, L. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000171123.60665.16 · Cited by 92
Coenzyme Q10: is there a clinical role and a case for measurement?
Molyneux, S. L., Young, J. M., Florkowski, C. M., Lever, M., & George, P. M. (2008) · PubMed Central · Cited by 87
Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 91
Antioxidants, Supplements, and Parkinson's Disease
Weber, C. A., & Ernst, M. E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g551 · Cited by 85
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
Xu, P., Li, D., Tang, X., Bao, X., Huang, J., Tang, Y., Yang, Y., Xu, H., & Fan, X. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84
Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
Duarte-Jurado, A. P., Gopar‐Cuevas, Y., Cárdenas, O. S., Loera‐Arias, M. D. J., Montes‐de‐Oca‐Luna, R., García‐García, A., & Rodríguez‐Rocha, H. (2021) · Antioxidants · doi:10.3390/antiox10030453 · Cited by 83
Oxidative stress and Parkinson's disease
Jenner, P. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83024-7 · Cited by 79
Coenzyme Q treatment of neurodegenerative diseases of aging
Galpern, W. R., & Cudkowicz, M. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.01.004 · Cited by 78
Therapeutic role of coenzyme Q10 in Parkinson's disease
Shults, C. W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.002 · Cited by 81
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development
Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 78
Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson’s Disease
Shahrani, M. M. A., Heales, S., Hargreaves, I. P., & Orford, M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6110100 · Cited by 79
Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the l-dopa
Agil, A., Durán, R., Barrero, F. J., Morales, B., Arauzo, M., Alba, F., León, M. T. M., Prieto, I., Ramírez, M. R., & Vives, F. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.016 · Cited by 71
α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy
Alleva, R., Nasole, E., Donato, F. D., Borghi, B., Neužil, J., & Tomasetti, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.119 · Cited by 71
An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients
Sohmiya, M., Tanaka, M., Suzuki, Y., Tanino, Y., Okamoto, K., & Yamamoto, Y. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.030 · Cited by 69
Self-citation
Analysis of coenzyme Q in human blood and tissues
Barshop, B. A., & Gangoiti, J. A. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.04.002 · Cited by 63
Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report
Mawatari, S., Ohara, S., Taniwaki, Y., Tsuboi, Y., Maruyama, T., & Fujino, T. (2020) · Parkinson s Disease · doi:10.1155/2020/2671070 · Cited by 58
Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson's Disease
Kim, J. H., Hwang, J., Shim, E., Chung, E.-J., Jang, S. H., & Koh, S. (2017) · Nutrition Research and Practice · doi:10.4162/nrp.2017.11.2.114 · Cited by 58
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement
Lorenzo, A. D., Iannuzzo, G., Parlato, A., Cuomo, G., Testa, C., Coppola, M., D’Ambrosio, G., Oliviero, D. A., Sarullo, S., Vitale, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051266 · Cited by 61
Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
Dragonas, C., Bertsch, T., Sieber, C. C., & Brosche, T. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.205 · Cited by 57
Quantitative Proteomics of a Presymptomatic A53T α-Synuclein Drosophila Model of Parkinson Disease
Xun, Z., Sowell, R. A., Kaufman, T. C., & Clemmer, D. E. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700467-mcp200 · Cited by 57
Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration
Niklowitz, P., Onur, S., Fischer, A., Laudes, M., Palussen, M., Menke, T., & Döring, F. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-73 · Cited by 55
Lipophilic antioxidants in neurodegenerative diseases
Chang, K., Cheng, M., Chiang, M.-C., & Chen, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.031 · Cited by 59
Coenzyme Q10 (Ubiquinol-10) Supplementation Improves Oxidative Imbalance in Children With Trisomy 21
Miles, M. V., Patterson, B. J., Chalfonte-Evans, M., Horn, P. S., Hickey, F. J., Schapiro, M. B., Steele, P. E., Tang, P., & Hotze, S. L. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.08.003 · Cited by 52
Role of Serum Cholesterol in Parkinson's Disease: A Meta-Analysis of Evidence
Gudala, K., Bansal, D., & Muthyala, H. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130196 · Cited by 50
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson’s Disease Patients
Gorgone, G., Currò, M., Ferlazzo, N., Parisi, G., Parnetti, L., Belcastro, V., Tambasco, N., Rossi, A., Pisani, F., Calabresi, P., et al. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8174-1 · Cited by 48
Management of the aging risk factor for Parkinson's disease
Phillipson, O. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.073 · Cited by 47
Dysregulation of stress systems and nitric oxide signaling underlies neuronal dysfunction in Alzheimer’s disease
Spiers, J. G., Chen, H. C., Bourgognon, J.-M., & Steinert, J. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.025 · Cited by 46
Physical activity affects plasma coenzyme Q10 levels differently in young and old humans
del Pozo-Cruz, J., Rodríguez-Bies, E., Ballesteros‐Simarro, M., Navas‐Enamorado, I., Tùng, B. T., Navas, P., & López‐Lluch, G. (2014) · Biogerontology · doi:10.1007/s10522-013-9491-y · Cited by 44
REDOX STATUS OF COENZYME Q 10 IS ASSOCIATED WITH CHRONOLOGICAL AGE
Wada, H., Goto, H., Hagiwara, S.-I., & Yamamoto, Y. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01209.x · Cited by 46
Self-citation
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 43
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Henchcliffe, C., Dodel, R. C., & Beal, M. F. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.002 · Cited by 42
Carotenoids: Role in Neurodegenerative Diseases Remediation
Gandla, K., Babu, A. K., Unnisa, A., Sharma, I., Singh, L. P., Haque, M. A., Dashputre, N. L., Baig, S., Siddiqui, F. A., Khandaker, M. U., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13030457 · Cited by 41
Improvement of the oral bioavailability of coenzyme Q10 by emulsification with fats and emulsifiers used in the food industry
Thanatuksorn, P., Kawai, K., Hayakawa, M., Hayashi, M. K., & Kajiwara, K. (2008) · LWT · doi:10.1016/j.lwt.2008.03.006 · Cited by 40
High-accuracy analysis system for the redox status of coenzyme Q10 by online supercritical fluid extraction–supercritical fluid chromatography/mass spectrometry
Matsubara, A., Harada, K., Hirata, K., Fukusaki, E., & Bamba, T. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.05.009 · Cited by 39
Total Cholesterol and the Risk of Parkinson's Disease: A Review for Some New Findings
Hu, G. (2009) · Parkinson s Disease · doi:10.4061/2010/836962 · Cited by 37
Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?
Leathem, A., Ortíz, T., Dennis, J. M., & Witting, P. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136923 · Cited by 36
Acute restraint stress induces rapid and prolonged changes in erythrocyte and hippocampal redox status
Spiers, J. G., Chen, H. C., Bradley, A. J., Anderson, S. T., Sernia, C., & Lavidis, N. A. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.05.011 · Cited by 34
The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim
Alrouji, M., Al-Kuraishy, H. M., Al-Mahammadawy, A.-K. A. A., Al-Gareeb, A. I., Saad, ‏. M., & Batiha, G. E. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06926-2 · Cited by 32
Increased oxidative stress and renal injury in patients with sepsis
Yamaguchi, J., Nagase, M., Yamamoto, Y., Sakurai, A., Kubo, A., Mitsuhashi, H., Matsuoka, M., Ihara, S., & Kinoshita, K. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-130 · Cited by 31
Self-citation
Qi-activating quercetin alleviates mitochondrial dysfunction and neuroinflammation in vivo and in vitro
Kang, S., Piao, Y., Kang, Y. C., Lim, S., & Pak, Y. K. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01238-x · Cited by 31
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10
Wada, H., Hagiwara, S.-I., Saitoh, E., Ieki, R., Okamura, T., Ota, T., Iguchi, M., Yuasa, K., Kodaka, T., Koishi, T., et al. (2005) · Pathophysiology · doi:10.1016/j.pathophys.2005.09.014 · Cited by 32
Self-citation
Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
van Vuuren, M. J., Nell, T. A., Carr, J. A., Kell, D. B., & Pretorius, E. (2020) · Biomolecules · doi:10.3390/biom11010030 · Cited by 33
Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases
Noelker, C., Hampel, H. J., & Dodel, R. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256398 · Cited by 29
Therapeutic Efficacy of Plasmalogens for Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer’s Disease
Fujino, T., Hossain, M. S., & Mawatari, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_14 · Cited by 31
Analysis of coenzyme Q10 in bee pollen using online cleanup by accelerated solvent extraction and high performance liquid chromatography
Xue, X., Zhao, J., Chen, L., Zhou, J., Yue, B., Li, Y., Wu, L., & Liu, F. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.12.085 · Cited by 28
Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases
dos Santos, G. C., Antunes, L. M. G., dos Santos, A. C., & Bianchi, M. D. L. P. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000400002 · Cited by 28
Association Between Serum Zinc Levels and the Risk of Parkinson’s Disease: a Meta-Analysis
Sun, H., Liu, X., Ge, H., Wang, T., Wang, Y., & Li, W. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-0941-2 · Cited by 27
A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium
Khan, M., Gross, J., Haupt, H., Jainz, A., Niklowitz, P., Scherer, H. H., Schmidt, F., Klapp, B. F., Reißhauer, A., & Mazurek, B. (2007) · Otolaryngology · doi:10.1016/j.otohns.2006.07.010 · Cited by 27
Coenzyme Q10 redox balance and a free radical scavenger drug
Yamamoto, Y. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.026 · Cited by 26
Self-citation
Determination of coenzyme Q10 tissue status via high-performance liquid chromatography with electrochemical detection in swine tissues (Sus scrofa domestica)
Niklowitz, P., Döring, F., Paulussen, M., & Menke, T. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.02.015 · Cited by 25
Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein
Li, G., Zou, L., Jack, C. R., Yang, Y., & Yang, E. S. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.005 · Cited by 25
Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review
Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060975 · Cited by 24
Impact of Genetic Variants of Apolipoprotein E on Lipid Profile in Patients with Parkinson's Disease
Gregório, M. L., Pinhel, M. A. S., Sado, C. L., Longo, G., Oliveira, F. N., Amorim, G. S., Nakazone, M. A., Florim, G. M. D. S., Mazeti, C. M., Martins, D. P., et al. (2013) · BioMed Research International · doi:10.1155/2013/641515 · Cited by 25
Plasma interleukin‐18 (IL‐18) levels are correlated with antioxidant vitamin coenzyme Q10 in preeclampsia
Roland, L., Gagné, A., Bélanger, M., Boutet, M., Julien, P., & Bilodeau, J. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903576020 · Cited by 24
Biomarkers for trials of neuroprotection in Parkinson's disease
Agarwal, P. A., & Stoessl, A. J. (2012) · Movement Disorders · doi:10.1002/mds.25065 · Cited by 23
Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Blagov, A. V., Postnov, A. Y., Sukhorukov, V. N., Popov, M. A., Uzokov, J., & Orekhov, A. N. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901036 · Cited by 26
Protective Efficacy of Coenzyme Q10 Against DDVP-Induced Cognitive Impairments and Neurodegeneration in Rats
Binukumar, B. K., Gupta, N., Sunkaria, A., Kandimalla, R. J. L., Wani, W. Y., Sharma, D. R., Bal, A., & Gill, K. D. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9289-0 · Cited by 22
Determination of coenzyme Q10 in human seminal plasma by high‐performance liquid chromatography and its clinical application
Li, K., Shi, Y., Chen, S., Li, W., Shang, X., & Huang, Y. (2006) · Biomedical Chromatography · doi:10.1002/bmc.645 · Cited by 22
Validation and application of an HPLC‐EC method for analysis of coenzyme Q10 in blood platelets
Miles, M. V., Tang, P., Miles, L., Steele, P. E., Moye, M. J., & Horn, P. S. (2008) · Biomedical Chromatography · doi:10.1002/bmc.1072 · Cited by 20
LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration
Zhang, S., Xie, J., Xia, Y., Yu, S., Gu, Z.-L., Feng, R., Luo, G., Wang, D., Wang, K., Jiang, M., et al. (2015) · Scientific Reports · doi:10.1038/srep12564 · Cited by 20
Stable Isotope Labeling and Label-Free Proteomics of Drosophila parkin Null Mutants
Xun, Z., Kaufman, T. C., & Clemmer, D. E. (2009) · Journal of Proteome Research · doi:10.1021/pr9006238 · Cited by 19
Determination of Reduced and Oxidized Coenzyme Q10 in Canine Plasma and Heart Tissue by HPLC-ECD: Comparison with LC-MS/MS Quantification
Schou‐Pedersen, A. M. V., Schemeth, D., & Lykkesfeldt, J. (2019) · Antioxidants · doi:10.3390/antiox8080253 · Cited by 17
The role of biomarkers and imaging in Parkinson’s disease
Algarni, M., & Stoessl, A. J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1135056 · Cited by 17
Decreased Coenzyme Q10 Concentration in Plasma of Children with Cystic Fibrosis
Oudshoorn, J. H., Lecluse, A. L. Y., van den Berg, R., Vaes, W. H. J., van der Laag, J., & Houwen, R. H. J. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000233193.77521.66 · Cited by 16
Oxidative Stress in Parkinson's Disease
Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16
Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans
Vasta, V., Sedensky, M. M., Morgan, P. G., & Hahn, S. H. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.09.002 · Cited by 15
Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran.
Saedi, S., Hemmati-Dinarvand, M., Barmaki, H., Mokhtari, Z., Musavi, H., Valilo, M., Mota, A., & Mahjoub, S. (2021) · PubMed Central · doi:10.22088/cjim.12.2.155 · Cited by 14
Effects of various concentrations of inhaled oxygen on tissue dysoxia, oxidative stress, and survival in a rat hemorrhagic shock model
Takasu, A., Iwamoto, S., Ando, S., Minagawa, Y., Kashiba, M., Yamamoto, Y., & Sakamoto, T. (2009) · Resuscitation · doi:10.1016/j.resuscitation.2009.03.018 · Cited by 14
Self-citation
Coenzyme Q10 as a Front-Line Antioxidant against Oxidative Stress
Yamamoto, Y. (2005) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.36.29 · Cited by 13
Self-citation
Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors
Ding, Y., Tang, F., Xue, X., Luo, J., Hussain, M., Huang, Y., Wang, Z., Jiang, H., Tu, Z., & Zhang, J. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.044 · Cited by 12
Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease
Ghanta, M. K., Elango, P., & Bhaskar, L. V. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200217114658 · Cited by 11
Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinsons Disease?
Kirches, E. (2009) · Current Genomics · doi:10.2174/138920209789503879 · Cited by 11
Blood and cerebrospinal fluid markers in Parkinson's disease: current biomarker findings
Henchcliffe, C. (2014) · Current Biomarker Findings · doi:10.2147/cbf.s50424 · Cited by 11

Authors: Sohmiya, M., Tanaka, M., Wei Tak, N., Yanagisawa, M., Tanino, Y., Suzuki, Y., Okamoto, K., & Yamamoto, Y.
Affiliations: Gunma University (JP)
The University of Tokyo (JP)
Tokyo University of Technology (JP)
Corresponding author: Sohmiya, Makoto
ORCID: Okamoto, Koichi
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 2004-08
Volume: 223
Issue: 2
Pages: 161-166
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/j.jns.2004.05.007
OpenAlex: W2117733672
Cited by: 143
References: 52
Citations by year: 2026: 3 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 5 · 2021: 7 · 2020: 14 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 7 · 2014: 4 · 2013: 8 · 2012: 6
FWCI: 2.84
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Keywords: Parkinson's disease, oxidative stress, coenzyme Q10, plasma biomarkers, redox state, neurodegeneration
MeSH terms: Adult, Aged, Aged, 80 and over, Alzheimer Disease, Chromatography, High Pressure Liquid, Coenzymes, Electrochemistry, Female, Humans, Male, Middle Aged, Oxidation-Reduction, Parkinson Disease, Plasma, Ubiquinone, Case-Control Studies, Oxidative Stress, Statistics, Nonparametric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks